Class II · Moderate risk Ongoing
Megestrol Acetate Oral Suspension
Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Megestrol Acetate Oral Suspension
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Supterpotent Drug
What was recalled
Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 cups), Rx Only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977 Dist. By: McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51
- Recalling firm
- Mckesson Corporation
- NDC code
- 63739-549-51
- Origin
- TN, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-1172-2018
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Megestrol recalls
See all
Class III · Low risk Terminated
Megestrol Acetate Oral Suspension
Reason Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.
Class III · Low risk Terminated
Megestrol Acetate Oral Suspension
Reason Subpotent Drug: Out of specification for assay (stability testing)
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.